The use of the lectin Helix pomatia agglutinin (HPA) as a prognostic indicator and as a tool in cancer research.

@article{Mitchell1999TheUO,
  title={The use of the lectin Helix pomatia agglutinin (HPA) as a prognostic indicator and as a tool in cancer research.},
  author={B. S. Mitchell and Udo Schumacher},
  journal={Histology and histopathology},
  year={1999},
  volume={14 1},
  pages={
          217-26
        }
}
Progress in treatment for cancer has enabled extension of the disease-free interval, and of the quality of life for patients, but there has been very little improvement in overall survival rates. The main reason for this has been the ineffectiveness of current therapies to kill all the cancer cells once they have spread to distant sites to form metastatic… CONTINUE READING